Roadzen (NASDAQ: RDZN) stock is down 55% on the culmination of the despac process. Roadzen merged into Vahanna Tech Edge Acquisition I Corp and started trading on Nasdaq last week. Since then we’ve seen that 55% fall in the value of the RDZN stock.
This is not something specific to this one deal though. As we’ve known for many months there were two similar companies coming to market: “Auto-focused insurtechs Cheche Group and Roadzen have both closed combinations with special purpose acquisitions companies and will trade as public companies on the Nasdaq.” Cheche is more insurance and China, Roadzen more roadside assistance and India - but the business lines, even if not the geographies, do run into each other.
Roadzen: “RoadZen, lnc. provides an online on-demand roadside assistance services with a network of towing and roadside repair providers in India. The company suite enables Insurers and Automotive OEMs with real-time customer interactions, rapid claims processing, and better risk underwriting services. It also offers services in the areas of towing and removal, battery jumpstart, flat tire support, locked out/lost keys, fuel problems, and roadside assistance.”
Roadzen stock price from Google Finance
As we noted last week about Cheche Group: “We’d suggest that this shows that the Spac route to market is a great deal less attractive than it was. Assuming that the reason to IPO is to raise capital then it’s a tactic - a strategy - that’s not really working any more. On the other hand, if the aim is simply to float in order to have paper to pay for things then it’s working just fine.
The outcome right now is that Cheche thought it had an enterprise value of $800 million and climbing, the current market capitalisation is $106 million. Ouch. So we can see why the vertiginous climb in the CCG stock price - to chase that enterprise value - but that’s not exactly how it has worked out, is it?”
It’s a little early to tell with Roadzen, it’s not been on the market long enough to settle properly. But we do have increasing doubts about the viability of the despac process as a viable route to market. It’s simply not producing the valuations that a more traditional IPO might.